University of California, Berkeley, and Stanford University.
University of California, Berkeley.
Behav Ther. 2023 Jan;54(1):101-118. doi: 10.1016/j.beth.2022.07.009. Epub 2022 Aug 2.
Understanding patient responsiveness, a component of fidelity, is essential as it impacts treatment outcome and ongoing use of treatment elements. This study evaluated patient responsiveness-operationalized as receptivity to treatment modules and ratings of the usefulness and the utilization of treatment elements-to the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in a sample of adults with serious mental illness (SMI) and sleep/circadian dysfunction. Adults with SMI and sleep/circadian dysfunction (N = 104) received TranS-C in a community mental health setting. Independent raters rated TranS-C sessions to assess receptivity. At posttreatment and 6-month follow-up, participants completed a usefulness scale, utilization scale, the PROMIS Sleep Disturbance (PROMIS-SD) and Sleep-Related Impairment (PROMIS-SRI) scales, DSM-5 Cross-Cutting Measure (DSM-5-CC), and Sheehan Disability Scale (SDS). Receptivity was rated as somewhat to fully understood, and predicted a reduction on the DSM-5-CC. On average, participants rated TranS-C as moderately useful and utilized treatment elements occasionally. Ratings of usefulness were associated with the PROMIS-SD, PROMIS-SRI, and DSM-5-CC at posttreatment, but not with the SDS. Ratings of utilization were not associated with outcome. The findings add to the literature on patient responsiveness, an implementation outcome, and provide data on the utility of TranS-C within a community mental health setting.
理解患者的反应性,即保真度的一个组成部分,至关重要,因为它会影响治疗效果和治疗元素的持续使用。本研究评估了患者对治疗模块的接受程度(操作性定义为对治疗元素的有用性和利用程度的接受程度),这是一种针对睡眠和昼夜节律障碍的跨诊断干预(TranS-C),在有严重精神疾病(SMI)和睡眠/昼夜节律障碍的成年人样本中。有 SMI 和睡眠/昼夜节律障碍的成年人(N=104)在社区心理健康环境中接受 TranS-C 治疗。独立评估者对 TranS-C 会议进行评估,以评估接受程度。在治疗后和 6 个月随访时,参与者完成了有用性量表、利用量表、PROMIS 睡眠障碍量表(PROMIS-SD)和睡眠相关障碍量表(PROMIS-SRI)、DSM-5 跨切分度量表(DSM-5-CC)和 Sheehan 残疾量表(SDS)。接受程度被评为有些理解到完全理解,并预测 DSM-5-CC 的减少。平均而言,参与者认为 TranS-C 是中等有用的,偶尔会利用治疗元素。有用性的评分与治疗后 PROMIS-SD、PROMIS-SRI 和 DSM-5-CC 相关,但与 SDS 无关。利用评分与结果无关。这些发现增加了对患者反应性(一种实施结果)的文献,并提供了在社区心理健康环境中 TranS-C 的实用性数据。